• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Molecular Cytogenetic Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global molecular cytogenetic market looks promising with opportunities in applications, such as genetic disorders, cancer, and personalized medicine. The global molecular cytogenetic market is expected to grow with a CAGR of 9%-11% from 2020 to 2025. The major drivers for this market are increasing incidence of genetic disorders & cancer and growing focus on targeted cancer treatment.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global molecular cytogenetic market report, please download the report brochure.
 
 

 
 
In this market, kits and reagents is the fastest growing product of molecular cytogenetics, whereas clinical and research laboratories is the fastest growing end user. Growth in various segments of the molecular cytogenetics market are given below:
 
 


 
The study includes trends and forecast for the global molecular cytogenetic market by product, technique, end user, application, and region as follows:
 
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Kits & Reagents
    • Testing Kits 
    • Probes 
    • Fluorescent Affinity Reagents 
    • Other Kits & Reagents 
  • Instruments 
  • Consumables 
  • Software & Services
By Technique [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Comparative Genomic Hybridization
    • Array-Based Comparative Genomic Hybridization 
    • Standard Comparative Genomic Hybridization 
  • Fluorescence in Situ Hybridization 
  • In Situ Hybridization 
  • Other Techniques 
 
By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Genetic Disorders 
  • Cancer 
  • Personalized Medicine 
  • Other Applications 

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Clinical & Research Laboratories 
  • Academic Research Institutes 
  • Pharmaceutical and Biotechnology Companies 
  • Other End Users 

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • Spain
    • Italy
    • France
  • Asia Pacific
    • China
    • Japan
    • India
  • The Rest of the World
    • Brazil
 

Some of the molecular cytogenetics companies profiled in this report include Roche, Danaher, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Illumina.

Lucintel forecasts that kits and reagents will remain the largest product segment over the forecast period due to the increasing incidence of genetic disorders and cancer.

Within this market, clinical and research laboratories will remain